Simulations Plus Sets Date for 2nd Quarter Fiscal Year 2010 Earnings Release and Conference Call
Conference Call to be on Thursday, April 15, at 12:00 noon EDT


LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP - News ), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report with the Securities and Exchange Commission on Wednesday, April 14, 2010, for the second quarter of its 2010 fiscal year ended February 28, 2010. Chairman and CEO Walt Woltosz will host a conference call and webinar to discuss the Company’s performance on Thursday, April 15, 2010, at 9:00 AM PDT / 12:00 noon EDT.

Shareholders and interested parties may join the conference call and webinar by first registering at the following link: https://www2.gotomeeting.com/register/638154122 . After registering you will receive a confirmation email with a unique link and instructions for joining the webinar. You may listen to the conference call by dialing 312-878-0218, and entering the access code 134-718-215.

About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development software, which is licensed to and used in the conduct of drug research by pharmaceutical, biotechnology, and drug delivery companies worldwide as well as in the study of environmental toxicology. The Company’s Words+ subsidiary, which provides assistive technology for persons with disabilities, and two retail products, Abbreviate! and FutureLab^™, comprise the remainder of the business. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” For more information, visit our Web site at: www.simulations-plus.com